138
Views
13
CrossRef citations to date
0
Altmetric
Review

The role of inflammation and interleukin-1 in acute cerebrovascular disease

&
Pages 121-128 | Published online: 20 Aug 2013

References

  • KeepRFHuaYXiGIntracerebral haemorrhage: mechanisms of injury and therapeutic targetsLancet Neurol20121172073122698888
  • MendelowADGregsonBARowanENMurrayGDGholkarAMitchellPMSTICH II InvestigatorsEarly surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas (STICH II): a randomised trialLancet Epub5292013
  • RockKLLatzEOntiverosFKonoHThe sterile inflammatory responseAnnu Rev Immunol20102832134220307211
  • LucasSMRothwellNJGibsonRMThe role of inflammation in CNS injury and diseaseBr J Pharmacol2006147Suppl 1S232S24016402109
  • AllanSMTyrrellPJRothwellNJInterleukin-1 and neuronal injuryNat Rev Immunol2005562964016034365
  • LuheshiNMKovacsKJLopez-CastejonGBroughDDenesAInterleukin-1alpha expression precedes IL-1beta after ischemic brain injury and is localised to areas of focal neuronal loss and penumbral tissuesJ Neuroinflammation2011818622206506
  • AmanteaDBagettaGTassorelliCMercuriNBCorasanitiMTIdentification of distinct cellular pools of interleukin-1beta during the evolution of the neuroinflammatory response induced by transient middle cerebral artery occlusion in the brain of ratBrain Res2010131325926920025855
  • DenesAFerencziSHalaszJKornyeiZKovacsKJRole of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouseJ Cereb Blood Flow Metab2008281707172118575457
  • GreenhalghADBroughDRobinsonEMGirardSRothwellNJAllanSMInterleukin-1 receptor antagonist is beneficial after subarachnoid haemorrhage in rat by blocking haem-driven inflammatory pathologyDis Model Mech2012582383322679224
  • LambertsenKLBiberKFinsenBInflammatory cytokines in experimental and human strokeJ Cereb Blood Flow Metab2012321677169822739623
  • TarkowskiERosengrenLBlomstrandCEarly intrathecal production of interleukin-6 predicts the size of brain lesion in strokeStroke199526139313987631343
  • HendrykSJarzabBJoskoJIncrease of the IL-1 beta and IL-6 levels in CSF in patients with vasospasm following aneurysmal SAHNeuro Endocrinol Lett20042514114715159698
  • LeeSCLiuWDicksonDWBrosnanCFBermanJWCytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 betaJ Immunol1993150265926678454848
  • RingheimGEBurgherKLHerouxJAInterleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brainJ Neuroimmunol1995631131238550808
  • TarkowskiERosengrenLBlomstrandCIntrathecal release of pro- and anti-inflammatory cytokines during strokeClin Exp Immunol19971104924999409656
  • ChenGYNunezGSterile inflammation: sensing and reacting to damageNat Rev Immunol20101082683721088683
  • PiccininiAMMidwoodKSDAMPening inflammation by modulating TLR signallingMediators Inflamm2010 Article ID 672395
  • SavageCDLopez-CastejonGDenesABroughDNLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injuryFront Immunol2012328823024646
  • NewtonKDixitVMSignaling in innate immunity and inflammationCold Spring Harb Perspect Biol20124119
  • WeberAWasiliewPKrachtMInterleukin-1 (IL-1) pathwaySci Signal2010193 (105):cm1.
  • Lopez-CastejonGBroughDUnderstanding the mechanism of IL-1beta secretionCytokine Growth Factor Rev20112218919522019906
  • AfoninaISTynanGALogueSEGranzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1alphaMol Cell20114426527822017873
  • ZhengYHumphryMMaguireJJBennettMRClarkeMCIntracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammationImmunity20133828529523395675
  • CasselSLSutterwalaFSSterile inflammatory responses mediated by the NLRP3 inflammasomeEur J Immunol20104060761120201012
  • MariathasanSWeissDSNewtonKCryopyrin activates the inflammasome in response to toxins and ATPNature200644022823216407890
  • LuheshiNMGilesJALopez-CastejonGBroughDSphingosine regulates the NLRP3-inflammasome and IL-1beta release from macrophagesEur J Immunol20124271672522105559
  • MartinonFPetrilliVMayorATardivelATschoppJGout-associated uric acid crystals activate the NALP3 inflammasomeNature200644023724116407889
  • PetrilliVPapinSDostertCMayorAMartinonFTschoppJActivation of the NALP3 inflammasome is triggered by low intracellular potassium concentrationCell Death Differ2007141583158917599094
  • HornungVLatzECritical functions of priming and lysosomal damage for NLRP3 activationEur J Immunol20104062062320201015
  • ShimadaKCrotherTRKarlinJOxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosisImmunity20123640141422342844
  • StrowigTHenao-MejiaJElinavEFlavellRInflammasomes in health and diseaseNature201248127828622258606
  • HenekaMTKummerMPStutzANLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 miceNature201349367467823254930
  • JhaSSrivastavaSYBrickeyWJThe inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18J Neurosci201030158111582021106820
  • YinYYanYJiangXInflammasomes are differentially expressed in cardiovascular and other tissuesInt J Immunopathol Pharmacol20092231132219505385
  • KummerJABroekhuizenREverettHInflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory responseJ Histochem Cytochem20075544345217164409
  • SchroderKTschoppJThe inflammasomesCell201014082183220303873
  • FaustinBLartigueLBrueyJMReconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activationMol Cell20072571372417349957
  • de Rivero VaccariJPLotockiGMarcilloAEDietrichWDKeaneRWA molecular platform in neurons regulates inflammation after spinal cord injuryJ Neurosci2008283404341418367607
  • de Rivero VaccariJPLotockiGAlonsoOFBramlettHMDietrichWDKeaneRWTherapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injuryJ Cereb Blood Flow Metab2009291251126119401709
  • AbulafaDPde Rivero VaccariJPLozanoJDLotockiGKeaneRWDietrichWDInhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in miceJ Cereb Blood Flow Metab20092953454419066616
  • FantuzziGKuGHardingMWResponse to local inflammation of IL-1 beta-converting enzyme-deficient miceJ Immunol1997158181818249029121
  • JoostenLANeteaMGFantuzziGInflammatory arthritis in caspase 1 gene-deficient mice: contribution of proteinase 3 to caspase 1-independent production of bioactive interleukin-1betaArthritis Rheum2009603651366219950280
  • TakenouchiTIwamaruYSugamaSThe activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1beta under acidic extracellular pH in LPS-primed microglial cellsJ Neurochem201111771272321395581
  • GrossOYazdiASThomasCJInflammasome activators induce interleukin-1alpha secretion via distinct pathways with differential requirement for the protease function of caspase-1Immunity20123638840022444631
  • LuheshiNMRothwellNJBroughDDual functionality of interleukin-1 family cytokines: implications for anti-interleukin-1 therapyBr J Pharmacol20091571318132919681864
  • LuheshiNMMcCollBWBroughDNuclear retention of IL-1 alpha by necrotic cells: a mechanism to dampen sterile inflammationEur J Immunol2009392973298019839011
  • VivianiBBartesaghiSGardoniFInterleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinasesJ Neurosci2003238692870014507968
  • ThorntonPPinteauxEGibsonRMAllanSMRothwellNJInterleukin-1-induced neurotoxicity is mediated by glia and requires caspase activation and free radical releaseJ Neurochem20069825826616805812
  • ThorntonPPinteauxEAllanSMRothwellNJMatrix metalloproteinase-9 and urokinase plasminogen activator mediate interleukin-1-induced neurotoxicityMol Cell Neurosci20083713514217939964
  • HalleAHornungVPetzoldGCThe NALP3 inflammasome is involved in the innate immune response to amyloid-betaNat Immunol2008985786518604209
  • DenesAWilkinsonFBiggerBChuMRothwellNJAllanSMCentral and haematopoietic interleukin-1 both contribute to ischaemic brain injury in miceDis Model Mech201361043104823519030
  • McCollBWRothwellNJAllanSMSystemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1-and neutrophil-dependent mechanismsJ Neurosci2007274403441217442825
  • McCollBWRothwellNJAllanSMSystemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in miceJ Neurosci2008289451946218799677
  • ThorntonPMcCollBWGreenhalghADenesAAllanSMRothwellNJPlatelet interleukin-1{alpha} drives cerebrovascular inflammationBlood20101153632363920200351
  • AllenCThorntonPDenesANeutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNAJ Immunol201218938139222661091
  • MeiselCSchwabJMPrassKMeiselADirnaglUCentral nervous system injury-induced immune deficiency syndromeNat Rev Neurosci2005677578616163382
  • WoiciechowskyCSchoningBLankschWRVolkHDDockeWDMechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepressionJ Mol Med (Berl)19997776978010619437
  • WeimarCRothMPZillessenGComplications following acute ischemic strokeEur Neurol20024813314012373029
  • GrabskaKGromadzkaGCzlonkowskaAInfections and ischemic stroke outcomeNeurol Res Int2011201169134821766026
  • StevensRDNyquistPAThe systemic implications of aneurysmal subarachnoid hemorrhageJ Neurol Sci200726114315617544451
  • IadecolaCAnratherJThe immunology of stroke: from mechanisms to translationNat Med20111779680821738161
  • WeissJMQuanNSundarSKWidespread activation and consequences of interleukin-1 in the brainAnn NY Acad Sci19947413383577825822
  • OffnerHVandenbarkAAHurnPDEffect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppressionNeuroscience20091581098111118597949
  • SundarSKBeckerKJCierpialMAIntracerebroventricular infusion of interleukin 1 rapidly decreases peripheral cellular immune responsesProc Natl Acad Sci U S A198986639864022548213
  • CataniaALonatiCSordiAGattiSDetrimental consequences of brain injury on peripheral cellsBrain Behav Immun20092387788419394418
  • ChamorroAAmaroSVargasMCatecholamines, infection, and death in acute ischemic strokeJ Neurol Sci2007252293517129587
  • BethinKEVogtSKMugliaLJInterleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activationProc Natl Acad Sci U S A2000979317932210922080
  • SmithCJEmsleyHCUdehCTInterleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppressionCytokine20125838438922445501
  • AgnihotriSCzapAStaffIFortunatoGMcCulloughLDPeripheral leukocyte counts and outcomes after intracerebral hemorrhageJ Neuroinflammation2011816022087759
  • DziedzicTBartusSKlimkowiczAMotylMSlowikASzczudlikAIntracerebral hemorrhage triggers interleukin-6 and interleukin-10 release in bloodStroke2002332334233512215608
  • BroughDTyrrellPJAllanSMRegulation of interleukin-1 in acute brain injuryTrends Pharmacol Sci20113261762221788085
  • RossJBroughDGibsonRMLoddickSARothwellNJA selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the ratNeuropharmacology20075363864217845807
  • SuzukiHSozenTHasegawaYChenWZhangJHCaspase-1 inhibitor prevents neurogenic pulmonary edema after subarachnoid hemorrhage in miceStroke2009403872387519875734
  • WuBMaQKhatibiNAc-YVAD-CMK decreases blood-brain barrier degradation by inhibiting caspase-1 activation of interleukin-1beta in intracerebral hemorrhage mouse modelTransl Stroke Res20101576420596246
  • YamasakiYMatsuuraNShozuharaHOnoderaHItoyamaYKogureKInterleukin-1 as a pathogenetic mediator of ischemic brain damage in ratsStroke199526676680 discussion 6817709417
  • PradilloJMDenesAGreenhalghADDelayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid ratsJ Cereb Blood Flow Metab2012321810181922781338
  • EmsleyHCSmithCJGeorgiouRFA randomised phase II study of interleukin-1 receptor antagonist in acute stroke patientsJ Neurol Neurosurg Psychiatry2005761366137216170078
  • ClarkSRMcMahonCJGueorguievaIInterleukin-1 receptor antagonist penetrates human brain at experimentally therapeutic concentrationsJ Cereb Blood Flow Metab20082838739417684519
  • GueorguievaIClarkSRMcMahonCJPharmacokinetic modelling of interleukin-1 receptor antagonist in plasma and cerebrospinal fluid of patients following subarachnoid haemorrhageBr J Clin Pharmacol20086531732517875190
  • ThomasSFellDAThe role of multiple enzyme activation in metabolic flux controlAdv Enzyme Regul19983865859762347
  • HopkinsALNetwork pharmacology: the next paradigm in drug discoveryNat Chem Biol2008468269018936753
  • SmallBGMcCollBWAllmendingerREfficient discovery of anti-inflammatory small-molecule combinations using evolutionary computingNat Chem Biol2011790290822020553